Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001553350-13-000459)

Filing Details

Accession Number:: 0001553350-13-000459
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-29 12:15:58
Reporting Period:: 2013-07-29

Filing Date:: 2013-07-29
Accepted Time:: 2013-07-29 12:15:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1476963	Heat Biologics Inc.	HTBX	Pharmaceutical Preparations (2834)	262844103

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1580270	Paul Belsky	C/O 100 Europa Drive Chapel Hill NC 27517		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-29	1,160	$0.00	44,639	No	4	C	Direct
Common Stock	Acquisiton	2013-07-29	51	$0.00	44,690	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B-1 Preferred	Disposition	2013-07-29	1,160	$0.00	1,160	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Dr. Belsky received 1,160 shares in lieu of Series B-1 Convertible Preferred Stock which converted at a conversion rate of .4348 per share.
These shares were issued upon consummation of the Company's initial public offering in lieu of Series B-2 Preferred Stock that Dr. Belsky had committed to purchase upon the Company's receipt of certain grant funding and the shares underlying the warrants to be issued at such time.